A field guide to testosterone care For the questions that matter.
FieldworkTHE TRT FIELD GUIDE
Menu
Medications · 4 MIN READ

Tlando vs Kyzatrex: why oral testosterone products are not interchangeable

Editorial research · Clinical review not completed

Tlando and Kyzatrex both contain oral testosterone undecanoate. That shared ingredient does not make them interchangeable capsules. Their prescribing information uses different approaches to monitoring and treatment decisions, so the product name belongs in every conversation about the prescription.

We reviewed their current DailyMed labels on September 21, 2026. This guide explains distinctions worth discussing with a clinician and pharmacist. It does not provide a personal dosing plan, recommend switching, or imply that the featured providers on this site dispense either product.

THE USEFUL PART, UP FRONT
  • Tlando is explicitly not substitutable with other oral testosterone undecanoate products.
  • Its fixed-regimen framework differs from Kyzatrex’s clinician-directed adjustment approach.
  • Use product-specific food, monitoring, and refill instructions.

Start with the exact approved product

Tlando’s label explicitly says it is not substitutable with other oral testosterone undecanoate products. Kyzatrex has its own approved labeling and instructions. A prescription for one should not be filled or taken as though the other were the same product in different packaging.

Keep the name on the prescription, pharmacy label, and medication guide aligned. If you are offered a different product, ask the prescriber to explain the change and issue the appropriate instructions. Our Kyzatrex versus Jatenzo guide examines another comparison within the same broad drug category.

Different labels describe different treatment decisions

Tlando uses a fixed labeled regimen with follow-up testosterone measurements used to determine whether treatment should continue or be discontinued. Kyzatrex’s label includes clinician-directed dose adjustment. Those are materially different frameworks even though both products are oral replacement therapy.

A reader should not take a dose-adjustment instruction from one label and apply it to the other. Ask the clinician what result would lead to continuing, changing, or stopping the prescribed medicine. Any such decision needs the complete clinical context, not only a number copied from a product comparison.

Food and laboratory timing are part of the prescription

Both labels direct use with food, but the monitoring instructions specify different timing for the blood sample relative to a dose. Those differences affect how the clinician interprets the result. A generic instruction to check testosterone sometime next month is less useful than a written plan tied to the actual product.

Ask what to do if your meal schedule varies and how to prepare for the ordered blood test. Record the time of the dose and relevant collection details as instructed. Do not move a dose or change the amount just to fit a lab appointment without checking with the treating professional.

Oral does not mean free of systemic risks

Both product labels include blood-pressure warnings and other testosterone precautions. Avoiding an injection does not avoid all treatment risks. Follow-up should account for blood pressure, blood count, response, adverse effects, and relevant medical history.

The labels also make clear that safety and efficacy for age-related hypogonadism have not been established. Being over 50, tired, or interested in a pill is not by itself an indication for treatment. Our TRT after 50 guide explains why the clinical assessment comes before the delivery-method preference.

Keep replacement therapy separate from fertility planning

Exogenous testosterone can suppress sperm production. An oral route does not remove that concern, and adding another medicine should not be represented as a guarantee of preserved fertility. Discuss near-term or future fertility goals before starting replacement treatment.

The fertility guide offers questions for that conversation. If specialist assessment is appropriate, ask how it fits into the plan rather than trying to select a product from marketing claims about convenience or hormone optimization.

Ask for the complete cost and access picture

We have not established a universal pharmacy price or insurance coverage for either product. Ask for the prescribed quantity, expected refill cycle, any authorization requirements, and the plan if the pharmacy cannot supply it. A change driven by availability still needs new product-specific instructions.

The useful comparison is the clinician’s rationale, the daily routine, monitoring, and the actual pharmacy quote. Shared ingredients can make two products sound similar; a careful reading of the labels shows why the decision needs more detail.

Sources & reading notes

Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Research checked September 21, 2026. Article updated September 21, 2026.

  1. DailyMed: TLANDO testosterone undecanoate prescribing information
  2. DailyMed: current KYZATREX prescribing information
  3. FDA: 2025 testosterone labeling changes and blood pressure warnings
  4. Endocrine Society: testosterone therapy clinical practice guideline
This article is educational and cannot determine whether TRT is appropriate for you. Discuss diagnosis, treatment, and follow-up with a qualified clinician.